Bioform Medical, which Focuses on developing and commercializing products that are used by physicians to enhance a patient’s appearance, filed terms with the SEC Monday for its upcoming IPO. The company plans to offer 10 million shares at a price range of $9 to $11 per share. JP Morgan and Piper Jaffray are the joint book runners on the deal.
